NEWS IN BRIEF
BioStem Technologies expands API site in Florida, US
The expansion will add environmentally controlled warehouse space for storage of the company’s active pharmaceutical ingredients (APIs), and a pack-out area for order fulfillment.
The company has also added a storage cage to handle US Drug Enforcement Administration (DEA) controlled substances with low to moderate potential for abuse.
BioStem Technologies COO Andrew Van Vurst told us it is in the process of applying to the Administration for Schedule III-V holding status, which will enable Quality Pharma Ingredients (QPI) to add DEA regulated products to its portfolio.
Van Vurst said he expects the expansion to be completed by the first quarter of 2018, and will create between five and eight new jobs across the quality, processing and warehouse sectors.
